Pfizer has beaten its earnings per share (EPS) estimates in its past 12 quarters. Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months.

Pfizer PFE will report its second-quarter 2025 earnings on Aug. 5, before market open. The Zacks Consensus Estimate for sales and earnings for the second quarter is pegged at $13.78 billion and 58 ...

Get the live share price of Pfizer Inc (PFE), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the July 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...

The call activity above the current Pfizer Inc. share price, increasing call premiums, and the lack of defensive put buying point to options traders expecting Pfizer to move higher from current price.